[New treatment strategies for multiple myeloma].
作者信息
Ozaki Shuji
出版信息
Rinsho Ketsueki. 2009 Oct;50(10):1506-17.
PMID:19915360
Abstract
摘要
相似文献
1
[New treatment strategies for multiple myeloma].
Rinsho Ketsueki. 2009 Oct;50(10):1506-17.
2
[Hematopoietic stem cell transplantation for multiple myeloma].
Rinsho Ketsueki. 2009 Oct;50(10):1420-6.
3
Treatment of multiple myeloma in the targeted therapy era.
Ann Pharmacother. 2009 Feb;43(2):329-38. doi: 10.1345/aph.1L428. Epub 2009 Feb 3.
4
Treatment of multiple myeloma: 2009 update.
Prescrire Int. 2009 Dec;18(104):263-6.
5
[Chemotherapy for multiple myeloma].
Nihon Rinsho. 2007 Dec;65(12):2280-4.
6
DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma.
Eur J Haematol. 2010 Mar;84(3):276-7. doi: 10.1111/j.1600-0609.2009.01372.x. Epub 2009 Nov 5.
7
Controversies regarding the use of dexamethasone in patients with multiple myeloma.
Clin Adv Hematol Oncol. 2008 Feb;6(2):103, 141.
8
Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
Jpn J Clin Oncol. 2009 Jul;39(7):449-55. doi: 10.1093/jjco/hyp046. Epub 2009 Jun 1.
9
[Treatment of transplant-eligible symptomatic multiple myeloma].
Rinsho Ketsueki. 2014 Oct;55(10):2016-26.
10
Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma.
J Clin Oncol. 2006 Jan 20;24(3):334-6. doi: 10.1200/JCO.2005.03.8851. Epub 2005 Dec 19.
Zotero 插件